Home6QC • FRA
add
Towa Pharmaceutical Co Ltd
Previous close
€16.90
Day range
€16.70 - €16.70
Year range
€15.70 - €20.60
Market cap
142.80B JPY
Avg Volume
2.00
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
Market news
Financials
Income Statement
Revenue
Net income
| (JPY) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 70.33B | 15.43% |
Operating expense | 18.73B | 17.32% |
Net income | 8.07B | 76.76% |
Net profit margin | 11.47 | 53.14% |
Earnings per share | — | — |
EBITDA | 12.26B | 10.91% |
Effective tax rate | 30.03% | — |
Balance Sheet
Total assets
Total liabilities
| (JPY) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 29.25B | -4.72% |
Total assets | 459.00B | 10.69% |
Total liabilities | 289.98B | 9.07% |
Total equity | 169.02B | — |
Shares outstanding | 49.23M | — |
Price to book | 0.00 | — |
Return on assets | 3.94% | — |
Return on capital | 4.60% | — |
Cash Flow
Net change in cash
| (JPY) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 8.07B | 76.76% |
Cash from operations | -2.96B | — |
Cash from investing | -11.43B | — |
Cash from financing | 1.38B | — |
Net change in cash | -12.02B | — |
Free cash flow | -21.11B | — |
About
Founded
1951
Website
Employees
4,588
